Completed
Phase 2
Age: 21Years - 50Years
All Genders
ID00000341
Pharmacokinetics and Bioavailability of Liquid vs Tablet Buprenorphine
Led by National Institute on Drug Abuse (NIDA) · Updated on 2017-01-12
1
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the steady-state pharmacokinetics and bioavailability of buprenorphine sublingual tablets vs. sublingual solution.
CONDITIONS
Brief Title
Evaluation of Liquid vs. Tablet Buprenorphine - 6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here